Anitha Vijayan

Anitha Vijayan

Auto-generated profile, based on publicly available information

Anitha Vijayan

Intermountain Kidney Services, Intermountain Health, Salt Lake City, Utah

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
EPEmilio D. Poggio
Emilio D. Poggio
RMRobyn L. McClelland
Robyn L. McClelland
KBKristina N. Blank
Kristina N. Blank
SHSpencer Hansen
Spencer Hansen
SBShweta Bansal
Shweta Bansal
FPfor the Kidney Precision Medicine Project
for the Kidney Precision Medicine Project
Background and objectives: Native kidney biopsies are commonly performed in the diagnosis of acute kidney diseases and CKD. Because of the invasive nature of the procedure, bleeding-related complications are not uncommon. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases–sponsored Kidney Precision Medicine Project requires that all participants undergo a kidney biopsy; therefore, the objective of this analysis was to study complication rates of native kidney biopsies performed using automated devices under kidney imaging. Design, setting, participants, & measurements: This is a systematic review and meta-analysis of the literature published from January 1983 to March 2018. The initial PubMed search yielded 1139 manuscripts. Using predetermined selection criteria, 87 manuscripts were included in the final analysis. A random effects meta-analysis for proportions was used to obtain combined estimates of complication rates. Freeman–Tukey double-arcsine transformations were used to stabilize variance as complications were rare. Results: A total of 118,064 biopsies were included in this study. Patient age ranged from 30 to 79 years, and 45% of patients were women. On the basis of our meta-analysis, pain at the site of biopsy is estimated to occur in 4.3% of biopsied patients, hematomas are estimated to occur in 11%, macroscopic hematuria is estimated to occur in 3.5%, bleeding requiring blood transfusions is estimated to occur in 1.6%, and interventions to stop bleeding are estimated to occur in only 0.3%. Death attributed to native kidney biopsy was a rare event, occurring only in an estimated 0.06% of all biopsies but only 0.03% of outpatient biopsies. Complication rates were higher in hospitalized patients and in those with acute kidney disease. The reported complications varied on the basis of study type and geographic location. Conclusions: Although the native kidney biopsy is an invasive diagnostic procedure, the rates of bleeding complications are low. Albeit rare, death can occur postbiopsy. Complications are more frequently seen after kidney biopsies of hospitalized patients with AKI.

1 July 2016 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
AVAnitha Vijayan
Anitha Vijayan
SFSarah Faubel
Sarah Faubel
DADavid J. Askenazi
David J. Askenazi
JCJorge Cerda
Jorge Cerda
WFWilliam H. Fissell
William H. Fissell
CTCharuhas V. Thakar
Charuhas V. Thakar

21 April 2020 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
KLKathleen D. Liu
Kathleen D. Liu
SGStuart L. Goldstein
Stuart L. Goldstein
AVAnitha Vijayan
Anitha Vijayan
CPChirag R. Parikh
Chirag R. Parikh
Kianoush KashaniKianoush Kashani
Kianoush Kashani
ONOn Behalf Of The Aki!Now Initiative Of The American Society Of Nephrology
On Behalf Of The Aki!Now Initiative Of The American Society Of Nephrology
The American Society of Nephrology has established a new initiative, AKI!Now, with the goal of promoting excellence in the prevention and treatment of AKI by building a foundational program that transforms education and delivery of AKI care, aiming to reduce morbidity and associated mortality and to improve long-term outcomes. In this article, we describe our current efforts to improve early recognition and management involving inclusive interdisciplinary collaboration between providers, patients, and their families; discuss the ongoing need to change some of our current AKI paradigms and diagnostic methods; and provide specific recommendations to improve AKI recognition and care. In the hospital and the community, AKI is a common and increasingly frequent condition that generates risks of adverse events and high costs. Unfortunately, patients with AKI may frequently have received less than optimal quality of care. New classifications have facilitated understanding of AKI incidence and its impact on outcomes, but they are not always well aligned with AKI pathophysiology. Despite ongoing research efforts, treatments to promote or hasten kidney recovery remain ineffective. To avoid progression, the current approach to AKI emphasizes the promotion of early recognition and timely response. However, a lack of awareness of the importance of early recognition and treatment among health care team members and the heterogeneity of approaches within the health care teams assessing the patient remains a major challenge. Early identification is further complicated by differences in settings where AKI occurs (the community or the hospital), and by differences in patient populations and cultures between the intensive care unit and ward environments. To address these obstacles, we discuss the need to improve education at all levels of care and to generate specific guidance on AKI evaluation and management, including the development of a widely applicable education and an AKI management toolkit, engaging hospital administrators to incorporate AKI as a quality initiative, and raising awareness of AKI as a complication of other disease processes.

17 December 2020 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
AVAnitha Vijayan
Anitha Vijayan

1 October 2021 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
AVAnitha Vijayan
Anitha Vijayan
EAEmaad M. Abdel-Rahman
Emaad M. Abdel-Rahman
KLKathleen D. Liu
Kathleen D. Liu
SGStuart L. Goldstein
Stuart L. Goldstein
AAAnupam Agarwal
Anupam Agarwal
JCJorge Cerda
Jorge Cerda
AKI is a common complication in hospitalized and critically ill patients. Its incidence has steadily increased over the past decade. Whether transient or prolonged, AKI is an independent risk factor associated with poor short- and long-term outcomes, even if patients do not require KRT. Most patients with early AKI improve with conservative management; however, some will require dialysis for a few days, a few weeks, or even months. Approximately 10%–30% of AKI survivors may still need dialysis after hospital discharge. These patients have a higher associated risk of death, rehospitalization, recurrent AKI, and CKD, and a lower quality of life. Survivors of critical illness may also suffer from cognitive dysfunction, muscle weakness, prolonged ventilator dependence, malnutrition, infections, chronic pain, and poor wound healing. Collaboration and communication among nephrologists, primary care physicians, rehabilitation providers, physical therapists, nutritionists, nurses, pharmacists, and other members of the health care team are essential to create a holistic and patient-centric care plan for overall recovery. Integration of the patient and family members in health care decisions, and ongoing education throughout the process, are vital to improve patient well-being. From the nephrologist standpoint, assessing and promoting recovery of kidney function, and providing appropriate short- and long-term follow-up, are crucial to prevent rehospitalizations and to reduce complications. Return to baseline functional status is the ultimate goal for most patients, and dialysis independence is an important part of that goal. In this review, we seek to highlight the varying aspects and stages of recovery from AKI complicating critical illness, and propose viable strategies to promote recovery of kidney function and dialysis independence. We also emphasize the need for ongoing research and multidisciplinary collaboration to improve outcomes in this vulnerable population.

1 May 2016 in Advances in Chronic Kidney Disease
Verified
Journal Article
Closed access
PDF file
FEFahad Edrees
Fahad Edrees
TLTingting Li
Tingting Li
AVAnitha Vijayan
Anitha Vijayan